LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Barclays Capital 2011 Global Healthcare Conference on Wednesday, March 16 at 2:00 p.m. (ET) in Miami, Florida.
